drugset / Trial / NCT04309656
Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid
RandomizedCrossoverOpen-labelTreatment
Summary
This is a single-dose, open-label, randomized, four-period, four-treatment, crossover study in healthy adult subjects.
Timeline
- Start
- 2020-01-14
- Primary completion
- 2020-02-28
- Completion
- 2020-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pretomanid | Small molecule | 10 mg | Oral |
| Subject | Pretomanid | Small molecule | 50 mg | Oral |
| Subject | Pretomanid | Small molecule | 200 mg | Oral |